ANACIN, created in 1982 (United States), from 1125 sister brands and 17477 competing brands. ANACIN is owned by Pfizer Inc, listed on the stock exchange of New York ANACIN is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Pfizer Inc
(ANACIN)
over 5 years*
USD 16.81